Final Exam Part 3 Flashcards
MOA of 1st generation antipsychotics
Dopamine receptor antagonists (DRAs)
D2 receptor blockers
dopamine pathway responsible for positive symptoms of schizophrenia
Mesolimbic
dopamine pathway responsible for negative symptoms of schizophrenia
mesocortical
mesocortical pathway:
dorsolateral prefrontal cortex regulate ______
cognition and executive function
mesocortical pathway:
Ventromedial prefrontal cortex regulate _______
emotions and affect
neurotransmitters involved in psychosis
dopamine, serotonin, GABA
MOA of atypical antipsychotics
Block D2 receptors at lower affinity
5HT2A antagonist
serotonin and dopamine
typical antipsychotics
Haldol - Mellaril. stelazine
Prolixin - thorazine Loxitane - compazine
Treatment for Acute dystonia
Benztropine (cogenitn) - anticholinergic
Treatment for pseudoparkinsonism
Benztropine (cogentin) - anticholinergic
Treatment for akathesia (restless)
Benzodiazepine or betablocker
Treatment for tardive dyskinesia
Switch to atypical or clozapine
VMAT2 inhibitor
side effects of typical antipsychotics
S - sedation/sunlight sensitivity/sexual SE
T - Tardive dyskinesia
A - Anticholinergic effects & Agranulocytosis
N - neuroleptic syndrome
C - Cardiac arrythmias
E - Extrapyramidal symptoms
Treatment of neuroleptic malignant syndrome
early detection - increased muscle tone, autonomic dysfunction - reduced consciousness
d/c med
manage symptoms
atypical antipsychotic with less sedating side effects
aripiprazole, iloperidone, lurasidone, paliperidone, risperidone, ziprasidone
*pines more sedating than dones